Javascript must be enabled to continue!
Single-nucleotide resolution detection of Topo IV cleavage activity in the Escherichia coli genome with Topo-Seq
View through CrossRef
Topoisomerase IV (Topo IV) is the main decatenation enzyme in Escherichia coli; it removes catenation links that are formed during DNA replication. Topo IV binding and cleavage sites were previously identified in the E. coli genome with ChIP-Seq and NorfIP. Here, we used a more sensitive, single-nucleotide resolution Topo-Seq procedure to identify Topo IV cleavage sites (TCSs) genome-wide. We detected thousands of TCSs scattered in the bacterial genome. The determined cleavage motif of Topo IV contained previously known cleavage determinants (−4G/+8C, −2A/+6 T, −1 T/+5A) and additional, not observed previously, positions −7C/+11G and −6C/+10G. TCSs were depleted in the Ter macrodomain except for two exceptionally strong non-canonical cleavage sites located in 33 and 38 bp from the XerC-box of the dif-site. Topo IV cleavage activity was increased in Left and Right macrodomains flanking the Ter macrodomain and was especially high in the 50–60 kb region containing the oriC origin of replication. Topo IV enrichment was also increased downstream of highly active transcription units, indicating that the enzyme is involved in relaxation of transcription-induced positive supercoiling.
Title: Single-nucleotide resolution detection of Topo IV cleavage activity in the Escherichia coli genome with Topo-Seq
Description:
Topoisomerase IV (Topo IV) is the main decatenation enzyme in Escherichia coli; it removes catenation links that are formed during DNA replication.
Topo IV binding and cleavage sites were previously identified in the E.
coli genome with ChIP-Seq and NorfIP.
Here, we used a more sensitive, single-nucleotide resolution Topo-Seq procedure to identify Topo IV cleavage sites (TCSs) genome-wide.
We detected thousands of TCSs scattered in the bacterial genome.
The determined cleavage motif of Topo IV contained previously known cleavage determinants (−4G/+8C, −2A/+6 T, −1 T/+5A) and additional, not observed previously, positions −7C/+11G and −6C/+10G.
TCSs were depleted in the Ter macrodomain except for two exceptionally strong non-canonical cleavage sites located in 33 and 38 bp from the XerC-box of the dif-site.
Topo IV cleavage activity was increased in Left and Right macrodomains flanking the Ter macrodomain and was especially high in the 50–60 kb region containing the oriC origin of replication.
Topo IV enrichment was also increased downstream of highly active transcription units, indicating that the enzyme is involved in relaxation of transcription-induced positive supercoiling.
Related Results
MARS-seq2.0: an experimental and analytical pipeline for indexed sorting combined with single-cell RNA sequencing v1
MARS-seq2.0: an experimental and analytical pipeline for indexed sorting combined with single-cell RNA sequencing v1
Human tissues comprise trillions of cells that populate a complex space of molecular phenotypes and functions and that vary in abundance by 4–9 orders of magnitude. Relying solely ...
Abstract 4180: Protocol-specific and coverage-based RNA-seq metrics characterize RNA integrity signatures across cohorts
Abstract 4180: Protocol-specific and coverage-based RNA-seq metrics characterize RNA integrity signatures across cohorts
Abstract
Background:
RNA degradation profoundly impacts transcript quantification and downstream biological interpretatio...
Abstract 317: p38γ MAPK regulates topoisomerase IIα activity by phosphorylation
Abstract 317: p38γ MAPK regulates topoisomerase IIα activity by phosphorylation
Abstract
DNA topoisomerase IIα (Topo IIα) is a critical target for cancer therapy and its protein expression, however, is frequently depleted by its inhibitors and s...
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract
Introduction
Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
Μελέτη της προβλεπτικής αξίας των γονιδίων BRCA1, ERCC1, ATP7B, PKM2, TOPO-1, TOPO-IIA, TOPO-IIB και C-MYC σε ασθενείς με μικροκυτταρικό καρκίνο του πνεύμονα που έλαβαν θεραπεία πρώτης γραμμής με σισπλατίνη και ετοποσίδη
Μελέτη της προβλεπτικής αξίας των γονιδίων BRCA1, ERCC1, ATP7B, PKM2, TOPO-1, TOPO-IIA, TOPO-IIB και C-MYC σε ασθενείς με μικροκυτταρικό καρκίνο του πνεύμονα που έλαβαν θεραπεία πρώτης γραμμής με σισπλατίνη και ετοποσίδη
Small cell lung cancer (SCLC) is the most aggressive form of lung cancer with poor prognosis. Combination chemotherapy remains the cornerstone in the treatment of both limited and ...
Analysis of the cleavage site of the human immunodeficiency virus type 1 glycoprotein: requirement of precursor cleavage for glycoprotein incorporation
Analysis of the cleavage site of the human immunodeficiency virus type 1 glycoprotein: requirement of precursor cleavage for glycoprotein incorporation
Endoproteolytic cleavage of the glycoprotein precursor to the mature SU and TM proteins is an essential step in the maturation of retroviral glycoproteins. Cleavage of the precurso...
Dynamic behavior of DNA topoisomerase IIβ in response to DNA double-strand breaks
Dynamic behavior of DNA topoisomerase IIβ in response to DNA double-strand breaks
AbstractDNA topoisomerase II (Topo II) is crucial for resolving topological problems of DNA and plays important roles in various cellular processes, such as replication, transcript...
The relationship between HER-2 and TOPO-2A gene expression and clinicopathologic results in gastric cancer.
The relationship between HER-2 and TOPO-2A gene expression and clinicopathologic results in gastric cancer.
e14670 Background: HER-2 and Topo-2A genes are settled on a chromosome 17 and their co-amplification rates are high. In this study, early gastric cancer patients who received adju...

